Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England.

Duerden B, Fry C, Johnson AP, Wilcox MH.

Open Forum Infect Dis. 2015 Mar 12;2(2):ofv035. doi: 10.1093/ofid/ofv035. eCollection 2015 Apr. Review.

2.

Changes to clinician attire have done more harm than good.

Dancer SG, Duerden BI.

J R Coll Physicians Edinb. 2014;44(4):293-8. doi: 10.4997/JRCPE.2014.410.

PMID:
25516900
3.

In memoriam--Professor J Gerald (Gerry) Collee CBE, FRSE, MD, FRCPath, FRCPE (1929-2013).

Duerden BI, Watt B, Poxton IR.

J Med Microbiol. 2014 Apr;63(Pt 4):623-4. doi: 10.1099/jmm.0.070508-0. Epub 2014 Feb 3. No abstract available.

PMID:
24493158
4.

Does ambulance response time influence patient condition among patients with specific medical and trauma emergencies?

Weiss S, Fullerton L, Oglesbee S, Duerden B, Froman P.

South Med J. 2013 Mar;106(3):230-5. doi: 10.1097/SMJ.0b013e3182882c70.

PMID:
23462493
5.

MRSA: why have we got it and can we do anything about it?

Duerden BI.

Eye (Lond). 2012 Feb;26(2):218-21. doi: 10.1038/eye.2011.314. Epub 2011 Dec 2.

6.

Contribution of a government target to controlling Clostridium difficile in the NHS in England.

Duerden BI.

Anaerobe. 2011 Aug;17(4):175-9. doi: 10.1016/j.anaerobe.2010.12.004. Epub 2010 Dec 21.

PMID:
21182972
7.

Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.

Jamal W, Rotimi VO, Brazier J, Duerden BI.

Anaerobe. 2010 Dec;16(6):560-5. doi: 10.1016/j.anaerobe.2010.09.003. Epub 2010 Sep 29.

PMID:
20887795
8.

Correlation of multidrug resistance, toxinotypes and PCR ribotypes in Clostridium difficile isolates from Kuwait.

Jamal WY, Rotimi VO, Grubesic A, Rupnik M, Brazier JS, Duerden BI.

J Chemother. 2009 Nov;21(5):521-6.

PMID:
19933043
9.

Responsibility for managing healthcare-associated infections: where does the buck stop?

Duerden BI.

J Hosp Infect. 2009 Dec;73(4):414-7. doi: 10.1016/j.jhin.2009.06.027. Epub 2009 Sep 17. Review.

PMID:
19765862
10.

Is the war being won?--An expert's view.

Duerden B.

Health Estate. 2009 Mar;63(3):59-61.

PMID:
19344002
11.

Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08.

Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, Duerden BI; HPA Regional Microbiology Network.

Euro Surveill. 2008 Oct 9;13(41). pii: 19000.

12.

Infection control measures to limit the spread of Clostridium difficile.

Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P; European C difficile-Infection Control Group; European Centre for Disease Prevention and Control (ECDC), van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O'Driscoll J, Patel B, Stone S, Wiuff C.

Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20. doi: 10.1111/j.1469-0691.2008.01992.x. Review.

13.

Controlling healthcare-associated infections in the NHS.

Duerden B.

Clin Med (Lond). 2008 Apr;8(2):140-3.

14.

Opinion on Millar et al., 'Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?'.

Duerden B.

J Hosp Infect. 2008 May;69(1):6-7; discussion 89. doi: 10.1016/j.jhin.2008.02.018. Epub 2008 Apr 2. No abstract available.

PMID:
18387696
15.

Confronting infection in the English National Health Service.

Duerden BI.

J Hosp Infect. 2007 Jun;65 Suppl 2:23-6. Review. No abstract available.

PMID:
17540236
16.

MRSA in non-clinical areas of hospitals.

Brown NM, Lee SD, Duerden BI, Gillanders SA, Cookson B, Neville L, Jenks P, Catchpole C, Wright P, Spencer RC.

J Hosp Infect. 2006 Dec;64(4):402-3. Epub 2006 Sep 18. No abstract available.

PMID:
16984805
17.
18.

Health protection: microbiology and the public health response to the bioterrorism threat.

Duerden BI.

Anaerobe. 2006 Apr;12(2):59-62. Epub 2005 Nov 14. Review. No abstract available.

PMID:
16701614
19.

Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains.

Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, Duerden BI.

J Antimicrob Chemother. 2006 Feb;57(2):212-20. Epub 2005 Dec 7.

PMID:
16338949
20.

Twenty-first-century medical microbiology services in the UK.

Duerden B.

Nat Rev Microbiol. 2005 Dec;3(12):979-83.

PMID:
16261176
21.

Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom.

Brett MM, Hood J, Brazier JS, Duerden BI, Hahné SJ.

Epidemiol Infect. 2005 Aug;133(4):575-82. Review.

22.

Extensive DNA inversions in the B. fragilis genome control variable gene expression.

Cerdeño-Tárraga AM, Patrick S, Crossman LC, Blakely G, Abratt V, Lennard N, Poxton I, Duerden B, Harris B, Quail MA, Barron A, Clark L, Corton C, Doggett J, Holden MT, Larke N, Line A, Lord A, Norbertczak H, Ormond D, Price C, Rabbinowitsch E, Woodward J, Barrell B, Parkhill J.

Science. 2005 Mar 4;307(5714):1463-5.

23.

Actinomyces dentalis sp. nov., from a human dental abscess.

Hall V, Collins MD, Lawson PA, Falsen E, Duerden BI.

Int J Syst Evol Microbiol. 2005 Jan;55(Pt 1):427-31.

PMID:
15653913
24.

Inspector of microbiology.

Duerden B.

Commun Dis Public Health. 2004 Mar;7(1):2-4. No abstract available.

PMID:
15137272
25.

Molecular characterization of nitroimidazole resistance in metronidazole-resistant bacteroides species isolated from hospital patients in Kuwait.

Jamal WY, Rotimi VO, Brazier JS, Johny M, Wetieh WM, Duerden BI.

Med Princ Pract. 2004 May-Jun;13(3):147-52.

26.

Actinomyces oricola sp. nov., from a human dental abscess.

Hall V, Collins MD, Hutson RA, Inganäs E, Falsen E, Duerden BI.

Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1515-8.

PMID:
13130041
27.

Actinomyces nasicola sp. nov., isolated from a human nose.

Hall V, Collins MD, Lawson PA, Falsen E, Duerden BI.

Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1445-8.

PMID:
13130031
28.

Corynebacterium atypicum sp. nov., from a human clinical source, does not contain corynomycolic acids.

Hall V, Collins MD, Hutson RA, Lawson PA, Falsen E, Duerden BI.

Int J Syst Evol Microbiol. 2003 Jul;53(Pt 4):1065-8.

PMID:
12892127
29.

Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait.

Rotimi VO, Jamal WY, Mokaddas EM, Brazier JS, Johny M, Duerden BI.

J Med Microbiol. 2003 Aug;52(Pt 8):705-9.

PMID:
12867566
30.

Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales.

Brazier JS, Hall V, Morris TE, Gal M, Duerden BI.

J Antimicrob Chemother. 2003 Aug;52(2):224-8. Epub 2003 Jul 1.

PMID:
12837734
31.

Actinobaculum urinale sp. nov., from human urine.

Hall V, Collins MD, Hutson RA, Falsen E, Inganäs E, Duerden BI.

Int J Syst Evol Microbiol. 2003 May;53(Pt 3):679-82.

PMID:
12807186
32.

Actinomyces vaccimaxillae sp. nov., from the jaw of a cow.

Hall V, Collins MD, Hutson R, Inganäs E, Falsen E, Duerden BI.

Int J Syst Evol Microbiol. 2003 Mar;53(Pt 2):603-6.

PMID:
12710633
33.

Characterization of some actinomyces-like isolates from human clinical sources: description of Varibaculum cambriensis gen nov, sp nov.

Hall V, Collins MD, Lawson PA, Hutson RA, Falsen E, Inganas E, Duerden B.

J Clin Microbiol. 2003 Feb;41(2):640-4.

34.

Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team.

Brazier JS, Duerden BI, Hall V, Salmon JE, Hood J, Brett MM, McLauchlin J, George RC.

J Med Microbiol. 2002 Nov;51(11):985-9.

PMID:
12448683
35.

An outbreak of serious illness and death among injecting drug users in England during 2000.

Jones JA, Salmon JE, Djuretic T, Nichols G, George RC, Gill ON, Brazier JS, Brett MM, Duerden BI, Fry NK, Hall V, Hope V, Lieftucht A, McLauchlin J, Pitcher DG, Weild A.

J Med Microbiol. 2002 Nov;51(11):978-84.

PMID:
12448682
36.

Sexually transmitted diseases: microbiology and management.

Birley H, Duerden B, Hart CA, Curless E, Hay PE, Ison CA, Renton AM, Richens J, Wyatt GB.

J Med Microbiol. 2002 Oct;51(10):793-807. Review. No abstract available.

PMID:
12435057
37.

Actinomyces cardiffensis sp. nov. from human clinical sources.

Hall V, Collins MD, Hutson R, Falsen E, Duerden BI.

J Clin Microbiol. 2002 Sep;40(9):3427-31.

38.

Fusobacterium necrophorum infections in England and Wales 1990-2000.

Brazier JS, Hall V, Yusuf E, Duerden BI.

J Med Microbiol. 2002 Mar;51(3):269-72.

PMID:
11871622
39.

PCR ribotyping of clinically important Clostridium difficile strains from Hungary.

Urbán E, Brazier JS, Sóki J, Nagy E, Duerden BI.

J Med Microbiol. 2001 Dec;50(12):1082-6.

PMID:
11761193
40.

Identification of clinical isolates of actinomyces species by amplified 16S ribosomal DNA restriction analysis.

Hall V, Talbot PR, Stubbs SL, Duerden BI.

J Clin Microbiol. 2001 Oct;39(10):3555-62.

41.

Wound microbiology and associated approaches to wound management.

Bowler PG, Duerden BI, Armstrong DG.

Clin Microbiol Rev. 2001 Apr;14(2):244-69. Review.

42.

Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes.

Rupnik M, Brazier JS, Duerden BI, Grabnar M, Stubbs SL.

Microbiology. 2001 Feb;147(Pt 2):439-47.

PMID:
11158361
43.

Infections in AIDS.

Hart CA, Beeching NJ, Duerden BI, Curry A, French N, Kariuki S, Graham SM, Gordon MA, Hoggard PG, Kewn S, Back DJ.

J Med Microbiol. 2000 Nov;49(11):947-67. Review. No abstract available.

PMID:
11073149
44.

Letters to the Editor.

Brazier JS, Stubbs SL, Duerden BI.

J Hosp Infect. 2000 Aug;45(4):332. No abstract available.

PMID:
10973755
45.
46.

Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.

Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M.

FEMS Microbiol Lett. 2000 May 15;186(2):307-12.

47.
48.

Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned?

Brazier JS, Stubbs SL, Duerden BI.

J Antimicrob Chemother. 1999 Oct;44(4):580-1. No abstract available.

PMID:
10588328
49.

Prevalence of toxin A negative/B positive Clostridium difficile strains.

Brazier JS, Stubbs SL, Duerden BI.

J Hosp Infect. 1999 Jul;42(3):248-9. No abstract available.

PMID:
10440000
50.

Commentary: a matter of good clinical practice.

Weinberg R, Duerden BI.

BMJ. 1999 Jun 12;318(7198):1617-8. No abstract available.

PMID:
10428554

Supplemental Content

Loading ...
Support Center